Prevention
Prevention 22/05/2012
NICE says sperm washing is no safer than effective treatment and timed intercourse
Draft UK guidance on fertility treatment says that sperm washing may no longer be necessary for couples where the man has HIV and the woman does not.
Prevention 19/05/2012
Opinion pieces recognize World AIDS Vaccine Day
An HIV vaccine would be the best tool for finally ending AIDS.
Prevention 18/05/2012
IAVI commemorates World AIDS Vaccine Day
New data illustrates potential impact of AIDS vaccine.
Prevention 18/05/2012
The quest for an HIV vaccine
There is broad scientific consensus that getting to zero new HIV infections will require an HIV vaccine. Modelling shows that even a partially effective HIV vaccine can save many lives and dollars over time.
Prevention 17/05/2012
Reformulated anti-HIV gel may be safe for use in both vagina, rectum
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum.
Prevention 16/05/2012
HIV prevention measures must include behavioral strategies to work, says APA
Truvada alone not sufficient, given adherence and other challenges.
Prevention 16/05/2012
GeoVax Labs reports 2012 first quarter financial results
Data from Phase 2a preventive HIV vaccine trial expected in late 2012; Phase 1/2 therapeutic vaccine trial patient enrollment advancing; Unprecedented preclinical results with adjuvanted vaccine – new human trial opened; Comments on Gilead Science’s Truvada® prevention submission.
Prevention 16/05/2012
Orasure in-home HIV test gets unanimous approval recommendation
Orasure’s oral swab-based rapid in-home HIV test has been recommended for approval by the U.S. Food and Drug Administration’s Blood Products Advisory Committee.
Prevention 15/05/2012
FDA sees benefits and risks with first over-the-counter HIV test for home use
The Food and Drug Administration is considering approval of the first over-the-counter HIV test that would allow consumers to quickly test themselves for the virus at home, without medical supervision.
Prevention 14/05/2012
NIH statement on HIV Vaccine Awareness Day - May 18, 2012
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.
Prevention 11/05/2012
AVAC urges FDA approval of PrEP following positive Advisory Committee recommendation; Lays out priorities to ensure access
Citing the urgent need for new HIV prevention options to stem HIV infections, AVAC urges the FDA to issue an approval for all men and women at risk, and is calling on public health agencies, governments, advocates and funders to take action to ensure access to TDF/FTC as PrEP.
Prevention 11/05/2012
Truvada receives PrEP approval recommendation
In a series of votes by the U.S. Food and Drug Administration’s Antiviral Drugs Advisory Committee, Truvada (tenofovir plus emtricitabine) has been recommended for approval as the first prescription drug—to be used daily and in conjunction with condoms and other safer-sex measures—to prevent HIV among those at risk for the infection.
Prevention 10/05/2012
Michel Sidibé: Make every day Mother's Day
"Together we can go from 390,000 children becoming infected with HIV each year to zero."
Prevention 10/05/2012
HIV epidemics driven by drug use set to spread due to Global Fund rule
The International HIV/AIDS Alliance warns of an impending HIV/AIDS crisis in Eastern Europe and Asia following its assessment of the impact of the cancellation of Global Fund Round 11 funding.
Prevention 10/05/2012
HIV prevention-in-a-pill is a must: Mitch explains
The question is whether PrEP can be cost effective? In certain scenarios, it can if it’s very well targeted at people who are at greatest risk and aren’t able to use condoms.
Prevention 10/05/2012
IAVI, GlycoMimetics, and Glycosensors and Diagnostics collaborate to develop novel AIDS vaccine candidate
A collaboration to develop an AIDS vaccine using novel compounds that mimic carbohydrates, called glycomimetics.
Prevention 10/05/2012
FDA offers generally favorable review of Truvada for PrEP
Although a favorable FDA analysis does not guarantee that the Advisory Committee will recommend licensing Truvada for PrEP, it carries some weight.
Prevention 09/05/2012
Plasma, cervical HIV load often discordant in 481-woman US group
HIV-infected women should be counseled that cervicovaginal inflammatory conditions may increase risk of sexual transmission of HIV, and medical providers advised to diagnose and treat such conditions as a means of reducing HIV transmission.
Prevention 09/05/2012
FDA panel considers HIV drug for new use
Advisers to weigh pros, cons of a $14,000-a-year drug for use in people at high risk of getting virus that causes AIDS.
Prevention 09/05/2012
UNAIDS launches "Believe it. Do it." action campaign to help end new HIV infections among children by 2015
The new campaign is aimed at bringing attention and action to the global goal of ending new HIV infections among children by 2015 and ensuring mothers living with HIV remain healthy.
More...
